Table 2

Agreement with statements on screening coverage and indications in rounds 1 and 2
Statement R1 N R1 % Agree(IQD) R2 % Agree(IQD)
Screening coverage
1. Screening for FASD at birth should be universal 87 58 (3) 55 (3)
2. Screening for FASD at birth should be targeted 88 68 (2) 76 (1)
3. Screening for FASD in childhood should be universal 86 49 (3) 40 (2)
4. Screening for FASD in childhood should be targeted 86 78 (1) 84 (1)
Indications for targeted screening - presentations
5. an alcohol-related event, illness or dependency in the birth mother 91 96 (1) -
6. a parent/foster parent who is concerned that their child might have a FASD 91 99 (1) -
7. prenatal alcohol exposure 90 92 (1) -
8. developmental delay 88 91 (1) -
9. growth retardation or failure to thrive 87 91 (1) -
10. structural central nervous system abnormalities 82 87 (1) -
11. neurological signs 84 82 (1) -
12. functional central nervous system abnormalities 84 88 (1) -
13. characteristic FAS facial anomalies 89 97 (1) -
14. birth defects 85 93 (1) -
15. reported or observed problems with behaviour 88 86 (1) -
Indications for targeted screening – high risk groups
16. children of mothers attending alcohol treatment services 91 93 (1) -
17. siblings of identified cases of FASD 90 96 (1) -
18. children who are diagnosed with ADHD 82 74 (2) -
19. children entering a child development service 89 87 (1) -
20. children entering child protection 86 85 (1) -
21. children entering foster care or adoptive placements (incl. kinship care) 86 87 (1) -
22. children entering a juvenile justice setting 84 82 (1) -

R1-Round 1; R2-Round 2; IQD-inter-quartile deviation.

Includes responses ‘agree’ and ‘strongly agree.’

Results for statements that reached 70% agreement (consensus) are presented in bold.

Watkins et al.

Watkins et al. BMC Pediatrics 2013 13:13   doi:10.1186/1471-2431-13-13

Open Data